Complement active fragment-loaded three-dimensional biomaterial for dental and/or other tissue regeneration

Patent metadata

Field	Value
Publication number	US-2022273850-A1
Application number	US-202017630052-A
Country	US
Kind code	A1
Filing date	Jul 31, 2020
Priority date	Aug 1, 2019
Publication date	Sep 1, 2022
Grant date	—

Abstract

A three-dimensional biomaterial including particles encapsulating at least one complement active fragment dispersed therein. Also, a process of manufacturing of the three-dimensional biomaterial with at least one biocompatible and/or resorbable polymer and the particles. The three-dimensional biomaterial is useful for tissue regeneration, especially with regards to dental pulp, dentin, periodontal and gingival tissues, as well as bones tissues.

First claim

1 .- 15 . (canceled)

16 . A biomaterial comprising:
a three-dimensional matrix made of at least one biocompatible and/or resorbable polymer, and particles encapsulating a complement component, a complement active fragment, or a combination thereof; said particles being dispersed in the three-dimensional matrix.

17 . The biomaterial according to claim 16 , wherein the biocompatible and/or resorbable polymer is selected from polysaccharides, proteins and any combinations or copolymers thereof.

18 . The biomaterial according to claim 16 , wherein the biocompatible and/or resorbable polymer is selected from collagen, chitosan, alginate and any combinations or copolymers thereof.

19 . The biomaterial according to claim 16 , wherein the encapsulating particles are polymeric microspheres.

20 . The biomaterial according to claim 19 , wherein the polymer of the microspheres is selected from biocompatible and/or biodegradable polyesters.

21 . The biomaterial according to claim 19 , wherein the polymer of the microspheres is selected from polycaprolactone (PCL), poly(lactic acid) (PLA), poly(glycolic acid) (PGA), polyhydroxybutyrate (PHB), poly(3-hydroxy valerate), poly(ethylene succinate) (PESu), poly(butylene succinate) (PBSu) and any combinations or copolymers thereof.

22 . The biomaterial according to claim 19 , wherein the polymeric microspheres are made of poly(lactic-co-glycolic acid) (PLGA).

23 . The biomaterial according to claim 16 , wherein the complement component and complement active fragment are selected from complement component C1, complement component C2, complement component C3, complement component C4, complement component C5, complement active fragments thereof and any combinations thereof.

24 . The biomaterial according to claim 16 , wherein the complement component and complement active fragment are selected from complement component C5 or C3.

25 . The biomaterial according to claim 16 , wherein the complement component and complement active fragment are selected from complement active fragment C5a or C3a.

26 . The biomaterial according to claim 16 , comprising PLGA microspheres encapsulating complement active fragment C5a, said microspheres being dispersed in a collagen three-dimensional matrix.

27 . The biomaterial according to claim 16 , further comprising a second phase made of a three-dimensional matrix made of at least one biocompatible and/or resorbable polymer which is free of particles encapsulating a complement component, a complement active fragment, or a combination thereof.

28 . The biomaterial according to claim 16 , wherein the three-dimensional matrix is porous.

29 . The biomaterial according to claim 16 , wherein the three-dimensional matrix is a hydrogel.

30 . A process for manufacturing the biomaterial according to claim 16 , said process comprising contacting particles encapsulating a complement component, a complement active fragment, or a combination thereof, with at least one biocompatible and/or resorbable polymer to form a three-dimensional matrix made of the at least one biocompatible and/or resorbable polymer in which the particles are dispersed.

31 . The process according to claim 30 , wherein the particles encapsulating a complement component, a complement active fragment, or a combination thereof, are contacted with the biocompatible and/or resorbable polymer by impregnation in a hydrogel prepared by dissolution of said polymer in an aqueous solution followed by homogenization.

32 . The process according to claim 31 , further comprising a step of water removal to provide the biomaterial under the form of a sponge.

33 . A method of tissue repair and/or tissue regeneration for a patient in need thereof, comprising contacting the tissue to be repaired and/or regenerated with the biomaterial according to claim 16 .

34 . The method according to claim 33 , wherein the tissue is selected from dental pulp, dentin, periodontal and gingival tissues.

35 . The method according to claim 34 , wherein the tissue is selected from bones, nervous tissues and skin tissues.

Assignees

• Septodont Ou Septodont Sas Ou Specialites Septodont
• Univ Aix Marseille
• Centre Nat Rech Scient

Inventors

• About Imad
• Richard Gilles
• Bergmann Madison
• Jeanneau Charlotte
• Djoudi Mounir

Classifications

• A61L2430/12

  for dental implants or prostheses · CPC title

• A61L2430/02

  for reconstruction of bones; weight-bearing implants · CPC title

• A61L2300/252

  Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines · CPC title

• A61L27/56 Primary

  Porous materials, {e.g. foams or sponges} · CPC title

• A61L27/54 Primary

  Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)} · CPC title